Internal Medicine Alert – July 15, 2007
July 15, 2007
View Issues
-
Salt! Bad for Slugs and Humans
Limiting dietary sodium can reduce blood pressure and morbidity and mortality from cardiovascular disease. -
Are Ureteral Stents More Trouble Than They're Worth?
In a systematic review and meta-analysis of worldwide data on the placement of ureteral stents after ureteroscopy in patients with kidney stones, the authors found higher morbidity with lower urinary tract problems ... -
A Randomized Trial for Treatment of Chronic Constipation
This study documents the safety and efficacy of oral polyethylene glycol for the long-term treatment of chronic constipation. -
Are Statin-induced Myopathic Symptoms Improved by Coenzyme Q10?
Statin-treated patients who developed symptoms of myopathy should be treated with at least 100 mg daily of coenzyme Q10 for a minimum of 30 days (assuming CPK values and/or other liver function tests are not abnormal) before discontinuing statin therapy. -
Levonorgestrel and Ethinyl Estradiol Tablets (Lybrel™)
The FDA has approved the first continuous, low dose, oral contraceptive for the prevention of pregnancy. -
Clinical Briefs By Louis Kuritzky, MD
Almost 90% of persons with type 2 diabetes (DM2) are overweight. Weight loss in DM2 consistently results in meaningful favorable changes in lipids, glucose, and insulin resistance, so the clinical community embraces tools to enhance weight loss in this population. -
ECG Review: Guess What the Cath Shows?
In this article, the ECG in the Figure was obtained from a 33-year old man who was admitted to the hospital with atypical chest pain. -
Pharmacology Watch
GlaxoSmithKline's rosiglitazone (Avandia) will receive a black box warning by the FDA because of concerns over heart failure associated with use of the drug.